色覚検査市場- 世界の産業規模、シェア、動向、機会、予測、検査タイプ別、技術別、エンドユーザー別、地域別、競合別、2020～2030年

色覚検査の世界市場は、2024年には3億2,342万米ドルとなり、予測期間には4億2,617万米ドルに達すると予測され、2030年までのCAGRは4.68%です。

世界の色覚検査市場は着実な成長を遂げており、その原動力となっているのは、色覚異常に対する意識の高まりと、視力障害の早期発見に対する需要の高まりです。色覚異常は人口のかなりの部分に影響を及ぼしており、色の識別が不可欠な日常生活や職業上の課題につながっています。学校、職場、ヘルスケア施設における視力検査プログラムの重視の高まりが、色覚検査の需要を高めています。モバイルアプリケーションやオンラインスクリーニングツールを含むデジタル検査ソリューションの進歩により、迅速で正確な評価を求める個人のアクセシビリティと利便性が向上しています。視力検査における人工知能（AI）の統合は診断精度をさらに高め、検査の信頼性と使いやすさを向上させています。

この市場を牽引しているのは、航空、防衛、ヘルスケア、運輸など、色覚が仕事のパフォーマンスや安全性に重要な役割を果たすさまざまな業界で色覚検査の採用が拡大していることです。特定の職業に対して視力検査を義務付ける政府の規制により、標準化された色覚検査の採用が増加しています。コンピュータ視力検査やバーチャルリアリティベースの検査など、眼科診断における技術革新は市場の展望を変えつつあります。視力ケア提供者と技術企業の協力関係の高まりは、革新的なソリューションの開発につながり、より包括的な色覚評価を可能にしています。

市場開発の課題としては、特に眼科医療サービスが限られている新興国では、色覚異常に対する認識不足が挙げられます。日常的な視力検査が行われていないため、多くの人が診断されないままであり、発見が遅れ、介入の選択肢が限られています。高度な診断ツールにかかる高額な費用も、特に資源に乏しい環境では普及の妨げになる可能性があります。さまざまな業界や地域で、規制遵守と色覚検査方法の標準化を確保することは、依然として複雑な課題です。このような課題にもかかわらず、ヘルスケア機関、教育機関、雇用主による視力健康意識の向上と定期的な色覚検査の実施に向けた取り組みが拡大しており、市場拡大の新たな機会が生まれると期待されています。

主な市場促進要因

色覚異常（CVD）の有病率の上昇

主な市場課題

高度診断技術の高コスト

検査手順の標準化の欠如

主要市場動向

視力ケアプログラムにおける色覚検査の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の色覚検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 検査タイプ別（オンライン色覚検査、クリニックでの色覚検査）
  • 技術別（印刷テスト、デジタル/ソフトウェアベースのテスト）
  • エンドユーザー別（ヘルスケア提供者、消費者、教育機関、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の色覚検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の色覚検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の色覚検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の色覚検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの色覚検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（ある場合）
• 製品の発売（ある場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Colorlite Ltd.
• EnChroma, Inc.
• X-Rite, Inc.
• ShiftVision
• Vivid Vision, Inc.
• Essilor Ltd
• Aptiv PLC
• Luna Imaging, Inc.
• Colorblind Awareness, Inc.
• Colblindor

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Color Blind Test Market was valued at USD 323.42 Million in 2024 and is expected to reach USD 426.17 Million in the forecast period with a CAGR of 4.68% through 2030. The Global Color Blind Test Market is experiencing steady growth, driven by increasing awareness of color vision deficiencies and the rising demand for early detection of vision disorders. Color blindness affects a significant portion of the population, leading to challenges in daily activities and professional careers where color differentiation is essential. Growing emphasis on vision screening programs in schools, workplaces, and healthcare facilities is increasing the demand for color vision tests. Advancements in digital testing solutions, including mobile applications and online screening tools, are improving accessibility and convenience for individuals seeking quick and accurate assessments. The integration of artificial intelligence (AI) in vision testing is further enhancing diagnostic precision, making tests more reliable and user-friendly.

The market is driven by the expanding adoption of color blindness testing in various industries, including aviation, defense, healthcare, and transportation, where color vision plays a critical role in job performance and safety. Government regulations mandating vision screening for specific professions are increasing the adoption of standardized color vision tests. Technological innovations in ophthalmic diagnostics, such as computerized vision screening and virtual reality-based testing, are transforming the market landscape. The growing collaboration between vision care providers and technology companies is leading to the development of innovative solutions, enabling more comprehensive color vision assessments.

Challenges in the market include the lack of awareness about color vision deficiencies, particularly in developing regions where eye care services are limited. Many individuals remain undiagnosed due to the absence of routine vision screening, leading to late detection and limited intervention options. High costs associated with advanced diagnostic tools may also hinder widespread adoption, particularly in resource-constrained settings. Ensuring regulatory compliance and standardization of color vision testing methods across different industries and regions remains a complex task. Despite these challenges, growing initiatives by healthcare organizations, educational institutions, and employers to promote vision health awareness and implement routine color vision screenings are expected to create new opportunities for market expansion.

Key Market Drivers

Rising Prevalence of Color Vision Deficiency (CVD)

The rising prevalence of Color Vision Deficiency (CVD) is a significant driver of the Global Color Blind Test Market. Recent studies have highlighted notable prevalence rates in various populations. For instance, a study among Egyptian university students reported a CVD prevalence of 6.9%, with red-green deficiencies accounting for 4.3% and total color blindness for 2.6%. The study also found that male students had a higher prevalence (7.7% for red-green and 5.5% for total color blindness) compared to female students (1.9% and 0.7%, respectively).

In the United States, historical data indicates that over 7.5% of boys and 0.6% of girls aged 12-17 years exhibited evidence of color vision deficiency. While these figures are from earlier studies, they underscore the persistent presence of CVD in the population. These statistics underscore the widespread occurrence of CVD, leading to an increased demand for early detection and routine testing, especially among populations with a higher genetic predisposition. As awareness surrounding CVD grows, more individuals are seeking diagnostic solutions to assess their color vision accuracy, leading to the expansion of the color blind test market.

The increasing use of digital screens and color-coded systems in various industries has further amplified the need for CVD testing. Professions such as aviation, healthcare, graphic design, and transportation require accurate color perception, making color blind tests an essential tool for pre-employment screening and regulatory compliance. Many governments and occupational health organizations mandate routine vision assessments, prompting employers and educational institutions to incorporate CVD testing into their standard evaluation processes. The growing importance of color vision in safety-critical jobs has led to higher adoption rates of color blind tests across different sectors.

Advancements in digital health technology have also contributed to market growth, making color vision testing more accessible. The rise of telehealth platforms and mobile-based applications has enabled individuals to take online color blind tests from the comfort of their homes, increasing test adoption rates. Schools and educational institutions are incorporating vision screening programs, further fueling demand. As the global prevalence of CVD continues to rise, the need for accessible, reliable, and cost-effective testing solutions is expected to drive significant growth in the Global Color Blind Test Market.

Key Market Challenges

High Cost of Advanced Diagnostic Technologies

The high cost of advanced diagnostic technologies presents a significant challenge in the Global Color Blind Test Market. Many modern diagnostic tools, such as digital and software-based color vision tests, rely on high-resolution imaging, artificial intelligence, and specialized ophthalmic equipment to provide precise assessments. These technologies often require substantial investment in research, development, and manufacturing, which drives up costs. Healthcare providers, clinics, and diagnostic centers may find it difficult to adopt these technologies due to budget constraints, particularly in developing regions where healthcare funding is limited. The high cost of procurement, installation, and maintenance of these advanced diagnostic systems can be a barrier for widespread adoption, restricting accessibility to accurate and comprehensive color blindness testing.

Patients also face financial burdens when seeking advanced color blind tests, as insurance coverage for vision-related screenings varies across regions. Many insurance providers do not cover routine color vision testing unless it is linked to a medical necessity, leaving individuals to bear the out-of-pocket expenses. This financial barrier discourages many from undergoing comprehensive evaluations, leading to undiagnosed or misdiagnosed cases. The lack of affordable options reduces the likelihood of early detection, preventing timely interventions that could improve quality of life and career opportunities for affected individuals.

Smaller clinics, educational institutions, and non-profit organizations aiming to offer widespread testing also struggle with financial feasibility. The need for highly skilled professionals to operate advanced diagnostic equipment further escalates costs, as specialized training and expertise are required. The challenge is intensified by the disparity in access to these technologies between urban and rural areas, limiting their availability to only well-funded healthcare institutions. Reducing the cost of these advanced technologies through innovation, government support, and strategic collaborations between healthcare providers and technology firms will be essential to overcoming this barrier in the Global Color Blind Test Market.

Lack of Standardization in Testing Procedures

The lack of standardization in testing procedures presents a significant challenge in the Global Color Blind Test Market. Color blindness tests vary widely in methodology, accuracy, and interpretation, leading to inconsistencies in diagnosis and assessment. Different healthcare providers, educational institutions, and online platforms use various testing techniques, including Ishihara plates, Farnsworth D-15, and digital screening tools. These tests may yield different results depending on lighting conditions, screen quality, and test administration methods, making it difficult to establish a universal standard for color vision deficiency diagnosis.

The absence of standardized guidelines affects both healthcare professionals and individuals undergoing testing. In clinical settings, variations in testing equipment and criteria for diagnosing color blindness can lead to misdiagnosis or discrepancies in severity classification. Some tests focus on red-green deficiencies, while others assess blue-yellow deficiencies, creating confusion in determining the exact type and extent of color vision impairment. For industries requiring color vision accuracy, such as aviation, transportation, and manufacturing, inconsistent testing protocols can lead to challenges in regulatory compliance and workforce screening. Individuals may receive conflicting results from different tests, impacting career eligibility, education accommodations, and daily activities reliant on color differentiation.

Regulatory bodies and professional organizations have yet to establish universal protocols for color blindness testing, limiting the reliability and comparability of results across different regions and industries. The lack of a globally recognized standard also affects research efforts in developing improved diagnostic tools and treatments. Efforts to implement standardized testing procedures, including digital calibration, uniform test scoring, and regulatory oversight, are essential to improving diagnostic consistency. Addressing this challenge is crucial for ensuring accurate color vision assessment, facilitating better patient outcomes, and enhancing the credibility of color blind tests in both medical and occupational settings.

Key Market Trends

Integration of Color Blind Testing in Vision Care Programs

The integration of color blind testing in vision care programs is a growing trend in the Global Color Blind Test Market. Vision care providers, including ophthalmologists, optometrists, and healthcare institutions, are increasingly incorporating color blindness screening as a standard part of routine eye examinations. As awareness of color vision deficiencies increases, early detection is becoming a priority in preventive eye care. Many vision care programs now recognize the importance of color vision assessment, particularly in children, where early diagnosis can aid in adapting learning environments to accommodate color vision deficiencies. Schools, pediatric clinics, and vision care centers are implementing regular screening to identify affected individuals at an early stage, improving support systems for those with color vision impairments.

The expansion of comprehensive eye care services is driving the adoption of color blind tests as an essential diagnostic tool. Many eye care centers are integrating both printed and digital color blind tests into their examination protocols to ensure a thorough assessment of patients' visual capabilities. Vision insurance providers are also beginning to cover color blindness screening as part of routine eye checkups, making these tests more accessible to a broader population. The inclusion of these screenings in occupational health programs is becoming more common, particularly in industries requiring precise color discrimination, such as healthcare, transportation, and design.

Technology-driven advancements in vision care solutions are also fueling this trend. Digital color vision tests, integrated with telemedicine platforms, allow for remote screening and early intervention. With increasing awareness of the impact of color blindness on daily activities and professional opportunities, healthcare organizations and governments are supporting initiatives that promote color vision assessments within public health strategies. As vision care programs continue to emphasize comprehensive eye health, the integration of color blind testing is expected to become a standard practice, supporting both early detection and effective management of color vision deficiencies.

Key Market Players

• Colorlite Ltd.
• EnChroma, Inc.
• X-Rite, Inc.
• ShiftVision
• Vivid Vision, Inc.
• Essilor Ltd
• Aptiv PLC
• Luna Imaging, Inc.
• Colorblind Awareness, Inc.
• Colblindor

Report Scope:

In this report, the Global Color Blind Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Color Blind Test Market, By Test Type:

• Online Color Blind Tests
• In-Clinic Color Blind Tests

Color Blind Test Market, By Technology:

• Printed Tests
• Digital/Software-Based Tests

Color Blind Test Market, By End User:

• Healthcare Providers
• Consumers
• Educational Institutions
• Others

Color Blind Test Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Color Blind Test Market.

Available Customizations:

Global Color Blind Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Color Blind Test Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Online Color Blind Tests, In-Clinic Color Blind Tests)
  • 5.2.2. By Technology (Printed Tests, Digital/Software-Based Tests)
  • 5.2.3. By End User (Healthcare Providers, Consumers, Educational Institutions, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Color Blind Test Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Color Blind Test Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Color Blind Test Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Color Blind Test Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End User

7. Europe Color Blind Test Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Color Blind Test Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Color Blind Test Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Color Blind Test Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Color Blind Test Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Color Blind Test Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End User

8. Asia-Pacific Color Blind Test Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Color Blind Test Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End User
  • 8.3.2. India Color Blind Test Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Color Blind Test Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Color Blind Test Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Color Blind Test Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End User

9. South America Color Blind Test Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Color Blind Test Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Color Blind Test Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Color Blind Test Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End User

10. Middle East and Africa Color Blind Test Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Technology
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Color Blind Test Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Color Blind Test Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Color Blind Test Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Colorlite Ltd.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. EnChroma, Inc.
• 14.3. X-Rite, Inc.
• 14.4. ShiftVision
• 14.5. Vivid Vision, Inc.
• 14.6. Essilor Ltd
• 14.7. Aptiv PLC
• 14.8. Luna Imaging, Inc.
• 14.9. Colorblind Awareness, Inc.
• 14.10. Colblindor

15. Strategic Recommendations

16. About Us & Disclaimer